HOURGLASS CAPITAL, LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HOURGLASS CAPITAL, LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$28,140
-57.4%
60,0000.0%0.01%
-56.5%
Q2 2023$66,000
-7.6%
60,0000.0%0.02%
-11.5%
Q1 2023$71,400
-20.1%
60,0000.0%0.03%
-16.1%
Q4 2022$89,400
-8.8%
60,0000.0%0.03%
-16.2%
Q3 2022$98,000
+104.2%
60,0000.0%0.04%
+117.6%
Q2 2022$48,000
-55.6%
60,0000.0%0.02%
-50.0%
Q1 2022$108,000
+4.9%
60,0000.0%0.03%0.0%
Q4 2021$103,000
+25.6%
60,000
+50.0%
0.03%
+54.5%
Q3 2021$82,000
-10.9%
40,0000.0%0.02%
+4.8%
Q2 2021$92,000
+64.3%
40,000
+100.0%
0.02%
+50.0%
Q1 2021$56,00020,0000.01%
Other shareholders
RECRO PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders